REVA Medical Reports Third Quarter 2018 Financial Results
05 nov. 2018 16h00 HE
|
REVA Medical Inc
SAN DIEGO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today provided...
REVA Announces Commercial Launch of the Fantom Encore Bioresorbable Scaffold
31 oct. 2018 19h19 HE
|
REVA Medical Inc
First Fantom Encore Implanted in the FANTOM Post Market Trial SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer...
REVA to Hold Third Quarter 2018 Financial Results Call
29 oct. 2018 19h20 HE
|
REVA Medical Inc
SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) has scheduled a conference call to review its third quarter 2018 financial results and provide a...
REVA Medical Presents Key Data Sets at the Transcatheter Cardiovascular Therapeutics Conference 2018
22 sept. 2018 22h42 HE
|
REVA Medical Inc
SAN DIEGO, Sept. 22, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, presented four key...
New Data for Fantom in Heart Attack Patients to be Presented at the TCT 2018 Conference
16 août 2018 00h05 HE
|
REVA Medical Inc
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, will present new data...
REVA Medical Reports Second Quarter 2018 Financial Results
07 août 2018 09h00 HE
|
REVA Medical Inc
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today provided...
REVA to Hold Second Quarter 2018 Financial Results Call
31 juil. 2018 19h04 HE
|
REVA Medical Inc
SAN DIEGO, July 31, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) has scheduled a conference call to review its second quarter 2018 financial results and provide a...
UPDATE: REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbable Scaffold for Below the Knee Therapy
26 juil. 2018 12h24 HE
|
REVA Medical Inc
SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that...
REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbale Scaffold for Below the Knee Therapy
25 juil. 2018 19h15 HE
|
REVA Medical Inc
SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that...
Reva Expands Commercial Access to Fantom With New Distribution Partnership in Italy
15 juil. 2018 18h59 HE
|
REVA Medical Inc
SAN DIEGO, July 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, is expanding commercial...